BTIG analyst Mark Massaro maintains MaxCyte (NASDAQ:MXCT) with a Buy and raises the price target from $10 to $11.
Why 3D Systems Stock Is Moving Higher Wednesday
The contract builds upon 3D systems key role as a supplier of 3D printing technology for producing clear aligners. Today, the company allows for the manufacture of about one million patient-specific clear aligners per day.
